ADVANCED NSCLC

Clinical trials for ADVANCED NSCLC explained in plain language.

Never miss a new study

Get alerted when new ADVANCED NSCLC trials appear

Sign up with your email to follow new studies for ADVANCED NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 2 Completed 1 Terminated 1

Experimental drug targets Hard-to-Treat lung cancer

Disease control Terminated

This study tested an experimental drug called REGN5093-M114, alone or with another drug, in people with advanced non-small cell lung cancer that has too much MET protein. The goal was to find a safe dose and see if it could shrink tumors. The study was stopped early, but the resu…

Matched conditions: ADVANCED NSCLC

Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 07:56 UTC

ADVANCED NSCLC

Get alerted when new ADVANCED NSCLC trials appear

Experimental drug targets Hard-to-Treat lung cancer